503 related articles for article (PubMed ID: 22704820)
21. Hepatic malignancies: percutaneous radiofrequency ablation during percutaneous portal or hepatic vein occlusion.
de Baere T; Deschamps F; Briggs P; Dromain C; Boige V; Hechelhammer L; Abdel-Rehim M; Aupérin A; Goere D; Elias D
Radiology; 2008 Sep; 248(3):1056-66. PubMed ID: 18632532
[TBL] [Abstract][Full Text] [Related]
22. Irreversible electroporation in porcine liver: short- and long-term effect on the hepatic veins and adjacent tissue by CT with pathological correlation.
Lee YJ; Lu DS; Osuagwu F; Lassman C
Invest Radiol; 2012 Nov; 47(11):671-5. PubMed ID: 23037001
[TBL] [Abstract][Full Text] [Related]
23. Microwave ablation of liver metastases guided by contrast-enhanced ultrasound: experience with 125 metastases in 39 patients.
Lorentzen T; Skjoldbye BO; Nolsoe CP
Ultraschall Med; 2011 Oct; 32(5):492-6. PubMed ID: 21259183
[TBL] [Abstract][Full Text] [Related]
24. Irreversible Electroporation of Hepatic and Pancreatic Malignancies: Radiologic-Pathologic Correlation.
Gonzalez-Beicos A; Venkat S; Songrug T; Poveda J; Garcia-Buitrago M; Poozhikunnath Mohan P; Narayanan G
Tech Vasc Interv Radiol; 2015 Sep; 18(3):176-82. PubMed ID: 26365548
[TBL] [Abstract][Full Text] [Related]
25. Predictors of Occlusion of Hepatic Blood Vessels after Irreversible Electroporation of Liver Tumors.
Tamura M; Pedersoli F; Schulze-Hagen M; Zimmerman M; Isfort P; Kuhl CK; Schmitz-Rode T; Bruners P
J Vasc Interv Radiol; 2020 Dec; 31(12):2033-2042.e1. PubMed ID: 33267950
[TBL] [Abstract][Full Text] [Related]
26. Radiofrequency ablation for unresectable tumors of the liver.
Howard JH; Tzeng CW; Smith JK; Eckhoff DE; Bynon JS; Wang T; Arnoletti JP; Heslin MJ
Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
[TBL] [Abstract][Full Text] [Related]
27. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of thermal injury to liver, pancreas and kidney during irreversible electroporation in an in vivo experimental model.
Dunki-Jacobs EM; Philips P; Martin RC
Br J Surg; 2014 Aug; 101(9):1113-21. PubMed ID: 24961953
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of resistance as a measure of successful tumor ablation during irreversible electroporation of the pancreas.
Dunki-Jacobs EM; Philips P; Martin RC
J Am Coll Surg; 2014 Feb; 218(2):179-87. PubMed ID: 24315888
[TBL] [Abstract][Full Text] [Related]
30. Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion.
de Baere T; Bessoud B; Dromain C; Ducreux M; Boige V; Lassau N; Smayra T; Girish BV; Roche A; Elias D
AJR Am J Roentgenol; 2002 Jan; 178(1):53-9. PubMed ID: 11756087
[TBL] [Abstract][Full Text] [Related]
31. Intraoperative radiofrequency ablation (RFA) for irresectable liver malignancies.
Tepel J; Hinz S; Klomp HJ; Kapischke M; Kremer B
Eur J Surg Oncol; 2004 Jun; 30(5):551-5. PubMed ID: 15135485
[TBL] [Abstract][Full Text] [Related]
32. Intraoperative radiofrequency ablation with or without tumorectomy for hepatocellular carcinoma in locations difficult for a percutaneous approach.
Kim HO; Kim SK; Son BH; Yoo CH; Hong HP; Cho YK; Kim BI
Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):591-6. PubMed ID: 20007075
[TBL] [Abstract][Full Text] [Related]
33. Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study.
Kawano Y; Sasaki A; Kai S; Endo Y; Iwaki K; Uchida H; Shibata K; Ohta M; Kitano S
Eur J Surg Oncol; 2009 Feb; 35(2):174-9. PubMed ID: 18325724
[TBL] [Abstract][Full Text] [Related]
34. Patterns of recurrence after ablation of colorectal cancer liver metastases.
Kingham TP; Tanoue M; Eaton A; Rocha FG; Do R; Allen P; De Matteo RP; D'Angelica M; Fong Y; Jarnagin WR
Ann Surg Oncol; 2012 Mar; 19(3):834-41. PubMed ID: 21879262
[TBL] [Abstract][Full Text] [Related]
35. Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical trial (COLDFIRE-2 trial).
Scheffer HJ; Vroomen LG; Nielsen K; van Tilborg AA; Comans EF; van Kuijk C; van der Meijs BB; van den Bergh J; van den Tol PM; Meijerink MR
BMC Cancer; 2015 Oct; 15():772. PubMed ID: 26497813
[TBL] [Abstract][Full Text] [Related]
36. Irreversible Electroporation in the Treatment of Hepatocellular Carcinoma.
Lencioni R; Crocetti L; Narayanan G
Tech Vasc Interv Radiol; 2015 Sep; 18(3):135-9. PubMed ID: 26365542
[TBL] [Abstract][Full Text] [Related]
37. Liver Function Tests Following Irreversible Electroporation of Liver Tumors: Experience in 174 Procedures.
Froud T; Venkat SR; Barbery KJ; Gunjan A; Narayanan G
Tech Vasc Interv Radiol; 2015 Sep; 18(3):140-6. PubMed ID: 26365543
[TBL] [Abstract][Full Text] [Related]
38. Hepatic resection with reconstruction of the inferior vena cava or hepatic venous confluence for metastatic liver tumor from colorectal cancer.
Aoki T; Sugawara Y; Imamura H; Seyama Y; Minagawa M; Hasegawa K; Kokudo N; Makuuchi M
J Am Coll Surg; 2004 Mar; 198(3):366-72. PubMed ID: 14992737
[TBL] [Abstract][Full Text] [Related]
39. Planning and follow-up after ablation of hepatic tumors: imaging evaluation.
Boonsirikamchai P; Loyer EM; Choi H; Charnsangavej C
Surg Oncol Clin N Am; 2011 Apr; 20(2):301-15, viii. PubMed ID: 21377585
[TBL] [Abstract][Full Text] [Related]
40. Irreversible Electroporation Can Effectively Ablate Hepatocellular Carcinoma to Complete Pathologic Necrosis.
Cheng RG; Bhattacharya R; Yeh MM; Padia SA
J Vasc Interv Radiol; 2015 Aug; 26(8):1184-8. PubMed ID: 26119204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
